GlassScriptPhysician profile
Ronald N Adamany
NPI 1992780688
$5,202.58
in general payments reported to CMS, 2019-2025
27 companies · $591 in 2025
The $591 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,629 · 2020: $378 · 2022: $1,576 · 2023: $231 · 2024: $797 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,619.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,084.31 | 2019-2025 | Rinvoq, Skyrizi |
| Pfizer INC. | $607.99 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $506.01 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $310.11 | 2019-2022 | |
| Allergan, INC. | $263.22 | 2019-2020 | |
| Genzyme Corporation | $256.34 | 2022-2025 | |
| Celgene Corporation | $160.56 | 2022 | |
| Covidien LP | $142.23 | 2019 | |
| Daiichi Sankyo INC. | $124.95 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $119.12 | 2019-2020 | |
| Gilead Sciences, INC. | $114.18 | 2019-2020 | |
| Janssen Biotech, INC. | $78.39 | 2020-2022 | |
| Vivus LLC | $68.97 | 2019-2022 | |
| Intercept Pharmaceuticals, INC. | $58.24 | 2019-2022 | |
| Braintree Laboratories, INC. | $48.66 | 2019-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $43.91 | 2022 | |
| Shionogi INC | $31.60 | 2019 | |
| Redhill Biopharma INC. | $26.70 | 2022 | |
| Nestle Healthcare Nutrition INC. | $25.55 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $24.75 | 2022 | |
| Axonics, INC. | $21.42 | 2022 | |
| W. L. Gore & Associates, INC. | $19.07 | 2020 | |
| Ironwood Pharmaceuticals, INC | $14.68 | 2022 | |
| Ferring Pharmaceuticals INC. | $14.25 | 2022 | |
| Boston Scientific Corporation | $14.02 | 2025 | Ingevity Mri |
| Medtronic, INC. | $12.03 | 2022 | |
| Dova Pharmaceuticals | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Adamany listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.